GEHC
GE HealthCare Technologies Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 29 ▼ GE HealthCare reported Q1 2026 revenue of $5.13B (+7.4% YoY) and GAA…
- Apr 30 to May 12 ▲ 5 days of insider buys: $5.8M by 7 insiders, avg $61.73
- May 15 to May 27 ▼ 2 sells: Gilbert Cisneros, Ro Khanna sold $1,001 - $15,000, last disclosed Jun 11
- May 22 ▲ 1 insider buy $641.8K at $64.18
- Jun 30 to Jul 30 ▲ 11 buys: Ro Khanna bought $1,001 - $15,000, last disclosed Aug 12
- Sep 11 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Oct 9
- Sep 22 Needham initiates
- Oct 7 Barclays initiates
- Oct 7 ▼ Ro Khanna sold $1,001 - $15,000, last disclosed Nov 9
- Oct 8 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Nov 9
- Oct 28 ▲ GE HealthCare reported Q3 2026 revenue of $5.5B (up 7.2% YoY) and di…
- Oct 28 ▲ Earnings: GEHC Q3 2026 Earnings: EPS $1.34 (+9.1% vs est)
Signal stack
Where each data set points today.
- InsidersBULLISH
8 insiders bought $6.4M at an average $61.97. No open-market sales. Price is 34% above their cost.
- InstitutionsBULLISH
Q3 2026: 58 added (1 new), 24 trimmed or exited. Largest new: Pzena Investment Management $82.1M.
- AnalystsBULLISH
21 of 29 rate it Buy or better. Median target $88.50 (+7%).
- Short sellersSTEADY
Short interest −5.8% to 18.26M shares. 4.9 days to cover, ≈4.0% of shares.
- TrendUPTREND
17% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| DODGE & COX | ADD | $3.2B |
| FMR LLC | ADD | $283.6M |
| Amundi | ADD | $206.6M |
| UBS Group AG | ADD | $147.3M |
| BARCLAYS PLC | DOUBLED | $144.4M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | $123.7M |
| FIL Ltd | DOUBLED | $118.0M |
| PZENA INVESTMENT MANAGEMENT LLC | NEW | $82.1M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
29 analystsPrice is inside the target range. Median implies +7%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 11, 2026 | Argus Research MAINTAIN | Buy |
| Nov 3, 2026 | UBS MAINTAIN | Neutral |
| Oct 29, 2026 | JP Morgan MAINTAIN | Neutral |
| Oct 29, 2026 | Citigroup MAINTAIN | Neutral |
| Oct 29, 2026 | RBC Capital MAINTAIN | Outperform |
| Oct 29, 2026 | Barclays MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Grogan William K Chief Financial Officer Sep 14, 2026 | AWARD | 62,256 sh |
Grogan William K Chief Financial Officer Sep 14, 2026 | AWARD | 12,840 sh |
Grogan William K Chief Financial Officer Sep 14, 2026 | AWARD | 31,877 sh |
O'Neill Kevin Michael CEO, PDx Sep 3, 2026 | TAX W/H | $50.7K |
Kass-Hout Taha Chief Technology Officer Sep 3, 2026 | TAX W/H | $106.0K |
Newcomb George A. Chief Accounting Officer Sep 3, 2026 | TAX W/H | $7.9K |
Estrampes Catherine Chief Commer. & Growth Officer Sep 3, 2026 | TAX W/H | $35.8K |
Jimenez Frank R GC & Corporate Secretary Sep 3, 2026 | TAX W/H | $104.4K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
13 filings · 2 bullish · 1 bearish · 10 neutral- NEUTRAL 8-KNov 5, 2026
GE HealthCare's Chief Science and Technology Officer Taha Kass-Hout notified the company of his…
Monitor for the naming of a successor and any strategic changes in the R&D or technology roadmap. The resignation of the top science officer without a stated reason or replacement introduces some…
- NEUTRAL 144Nov 4, 2026
James Saccaro, a former officer of GE HealthCare Technologies Inc., filed a Form 144 notice of…
This is a routine insider sale by a former officer exercising stock options. The dollar amount is small relative to market cap. Monitor for any additional insider selling patterns in future filings…
- BULLISH 8-KOct 28, 2026
GE HealthCare reported Q3 2026 revenue of $5.5B (up 7.2% YoY) and diluted EPS of $1.36 (up 39.1%…
The strong beat and raised guidance signal accelerating momentum across all segments, particularly in Pharmaceutical Diagnostics (13.8% organic growth) and Patient Care Solutions (8.8% organic…
- BULLISH INST-CLUSTEROct 19, 2026
Five institutional investors added to their GE HealthCare positions in Q3 2026, with aggregate…
Five institutional investors added to their GE HealthCare positions in Q3 2026, with aggregate holdings rising by $20.7M to $32.0M. The buying is concentrated among asset managers, with Assenagon…
All GEHC filing & press-release reports (13)
- 8-K reportNov 5, 2026
- 144 reportNov 4, 2026
- 8-K reportOct 28, 2026
- INST-CLUSTER reportOct 19, 2026
- 8-K reportSep 22, 2026
- 3 reportSep 16, 2026
- 8-K reportJul 29, 2026
- CLUSTER reportMay 13, 2026
- CLUSTER reportApr 30, 2026
- 8-K reportMay 11, 2026
- CLUSTER reportApr 30, 2026
- 8-K reportApr 29, 2026
- DEFA14A reportMar 19, 2026